Express News | CSPC Innovation Pharmaceutical: SYS6043 antibody-drug conjugate has received clinical trial approval.

BreakingsDec 20 15:55

Express News | Cspc innovation pharmaceutical: The application for issuing shares to purchase assets and raise supporting funds has been accepted.

BreakingsDec 8 17:10

CSPC Innovation Pharmaceutical Get US FDA Fast Track Qualification for Cervical Cancer Drug

MT NewswiresDec 5 15:49

Express News | cspc innovation pharmaceutical: cspc pharma giant stone biopharmaceutical co., ltd. authorized drug obtains fast track designation from the usa FDA.

BreakingsDec 4 16:02

Express News | cspc innovation pharmaceutical: The market application for Ustinue monoclonal antibody injection has been accepted.

BreakingsNov 26 16:24

cspc innovation pharmaceutical (300765.SZ): Giant Stone Biological's therapeutic vaccine SYS6026 has been approved to conduct clinical trials.

Gelonghui November 12th 丨 CSPC Innovation Pharmaceutical (300765.SZ) announced that its holding subsidiary CSPC Pharma Horizepharma Co., Ltd. (hereinafter referred to as “Horizepharma”) recently received the Drug Clinical Trial Approval Notice for the Therapeutic Vaccine SYS6026 for the treatment of related precancerous lesions caused by human papillomavirus (HPV) issued by the National Medical Products Administration, and will soon conduct clinical trials. SYS6026 is the company's first therapeutic vaccine developed based on its mRNA platform, delivered by messenger RNA (mRNA) molecules bound to lipid nanoparticles (LNP).

Gelonghui FinanceNov 12 16:26